Resumen
Diferenciales
Común
- Purpura simplex
- Actinic purpura (also known as senile purpura)
- Medications
- Alcohol use disorder
- Drug-induced thrombocytopenia
- Platelet storage pool disease
- von Willebrand disease (vWD)
- Vitamin K deficiency
- Cirrhosis
- Vasculitis
Infrecuente
- Hereditary hemorrhagic telangiectasia (HHT)
- Cushing syndrome
- Child abuse
- Elder abuse
- Immune thrombocytopenia (ITP)
- Thrombotic thrombocytopenic purpura (TTP)
- Hemolytic uremic syndrome (HUS)
- Disseminated intravascular coagulation
- Wiskott-Aldrich syndrome
- MYH9-related disorders
- Bernard-Soulier disease
- Thrombocytopenia with absent radius syndrome
- Glanzmann thrombasthenia
- Acute myelogenous leukemia
- Acute lymphocytic leukemia
- Hodgkin lymphoma
- Non-Hodgkin lymphoma
- Multiple myeloma
- Solid tumor with infiltration of bone marrow
- Myelofibrosis
- Myelodysplastic syndrome
- Aplastic anemia
- Hemophilia
- Factor V, VII, X, or XI deficiency
- Acquired coagulation inhibitors
- Vitamin C deficiency
- Marfan syndrome
- Ehlers-Danlos syndrome
- Acute liver failure
- Gardner-Diamond syndrome
Colaboradores
Autores
Tzu-Fei Wang, MD
Assistant Professor of Internal Medicine
The Ohio State University
Columbus
OH
Divulgaciones
TW declares that she has received an honorarium from Daiichi Sankyo.
Eric H. Kraut, MD
Professor of Internal Medicine
The Ohio State University
Columbus
OH
Divulgaciones
EHK declares that he has no competing interests.
Revisores por pares
Donald M. Arnold, MDCM, MSc
Associate Professor
Department of Medicine
McMaster University
Hamilton
Ontario
Canada
Divulgaciones
DMA has received speaking honoraria from Amgen for presentation on immune thrombocytopenia; consulting fees from Amgen, and Bristol-Myers Squibb for ITP related studies; and research grants from Amgen, GlaxoSmithKline, and Hoffman-La Roche for clinical studies in ITP. He is co-author of a reference cited in this topic.
Deborah Siegel, MD, MSc, FRCPC
Clinical Scholar
McMaster University
St. Joseph’s Healthcare Hamilton
Hamilton
Ontario
Canada
Divulgaciones
DS declares that she has no competing interests.
Riten Kumar, MD, MSc
Assistant Professor of Pediatrics
Nationwide Children’s Hospital
Ohio State University
Columbus
OH
Divulgaciones
RK declares that he has no competing interests.
David Keeling, BSc, MD, FRCP, FRCPath
Consultant Haematologist
Oxford Haemophilia & Thrombosis Centre
Churchill Hospital
Oxford
UK
Divulgaciones
DK declares that he has no competing interests.
Professor Cheng-Hock Toh, MBChB, MD, FRCP, FRCPath
Professor of Haematology
University of Liverpool
Liverpool
UK
Divulgaciones
CHT declares that he has no competing interests.
Shankaranarayana Paneesha, MBBS, MD, FRCP, FRCPath
Consultant Haematologist
Heart of England NHS Foundation Trust
Birmingham
UK
Divulgaciones
SP has received a speaker fee from Janssen.
Agradecimiento de los revisores por pares
Los temas de BMJ Best Practice se actualizan de forma continua de acuerdo con los desarrollos en la evidencia y en las guías. Los revisores por pares listados aquí han revisado el contenido al menos una vez durante la historia del tema.
Divulgaciones
Las afiliaciones y divulgaciones de los revisores por pares se refieren al momento de la revisión.
Referencias
Artículos principales
Faughnan ME, Mager JJ, Hetts SW, et al. Second international guidelines for the diagnosis and management of hereditary hemorrhagic telangiectasia. Ann Intern Med. 2020 Dec 15;173(12):989-1001.Texto completo Resumen
Tiede A, Collins P, Knoebl P, et al. International recommendations on the diagnosis and treatment of acquired hemophilia A. Haematologica. 2020 Jul;105(7):1791-801.Texto completo Resumen
Neunert C, Terrell DR, Arnold DM, et al. American Society of Hematology 2019 guidelines for immune thrombocytopenia. Blood Adv. 2019 Dec 10;3(23):3829-66.Texto completo Resumen
Rodeghiero F, Tosetto A, Abshire T, et al. ISTH/SSC bleeding assessment tool: a standardized questionnaire and a proposal for a new bleeding score for inherited bleeding disorders. J Thromb Haemost. 2010;8:2063-2065.Texto completo Resumen
Platton S, Baker P, Bowyer A, et al. Guideline for laboratory diagnosis and monitoring of von Willebrand disease: a joint guideline from the United Kingdom Haemophilia Centre Doctors' Organisation and the British Society for Haematology. Br J Haematol. 2024 May;204(5):1714-31.Texto completo
Artículos de referencia
Una lista completa de las fuentes a las que se hace referencia en este tema está disponible para los usuarios con acceso a todo BMJ Best Practice.
El uso de este contenido está sujeto a nuestra cláusula de exención de responsabilidad